LUCAS Chest Compression System (Jolife) – Demonstration Unit Risk (2025)
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
LUCAS 2, 3 and 3.1 LUCAS chest compression System is to be used for performing external cardiac compressions on adult patients who have acute circulatory arrest defined as absence of spontaneous breathing and pulse, and loss of consciousness.
Brand
Jolife AB Scheelevagen 17 Ideon Science Park Lund Sweden
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Lucus 2 Catalog Number: 99576-000025 UDI-DI code: 00883873904565 Serial Number: 30090111 Lucas 3 Catalog Number: 21331-000081 UDI-DI code: 00883873861875 Serial Numbers: 35172335 35160570 Lucas 3.1 Catalog Number: 94576-000005 UDI-DI code: 00883873834329 Serial Numbers: 3518A164 3518D104 (Scrapped)
Jolife AB Scheelevagen 17 Ideon Science Park Lund Sweden is recalling LUCAS 2, 3 and 3.1 LUCAS chest compression System is to be used for performing external cardiac com due to Due to demonstration units of chest compression system being provided to a customer which may potentially be utilized for clinical use.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Due to demonstration units of chest compression system being provided to a customer which may potentially be utilized for clinical use.
Recommended Action
Per FDA guidance
On 05/21/2025, the firm send via certified mail an "URGENT: MEDICAL DEVICE RECALL" Letter to customers informing them that demonstration LUCAS devices were given to customers for use without the proper labeling. These demonstration units are not maintained in a clinically usable state and are not to be loaned to customers or used in a clinical setting. Customer are instructed to: 1. Immediately check their internal inventory to locate the product listed on the attached business reply form, stop usage, and remove them from their point of use. 2. Return the enclosed business reply form by email to RSRecall@Stryker.com to confirm receipt of this notification. 3. Upon receipt of the completed business reply form, Stryker will contact customers to arrange for the return and replacement of the affected product(s). 4. Maintain awareness of this communication internally until all required actions have been completed within their facility. Keep this communication close to the affected items until replacement. 5. Inform Stryker if any of the subject devices have been distributed to other organizations. If so, provide contact details so Stryker can inform the recipients appropriately. Any questions or concerns, contact Customer Service +1 800 787 9537, option 2, from 8:00 AM to 7:00 PM (Eastern Time), Monday Friday or by email at medtechsup@stryker.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026